Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 7 - Drugs for disorders of the blood or the extracellular fluid
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
12/2009
12/03/2009WO2009143662A1 Pharmaceutical composition comprising calcium blocker and b family vitamins and the use thereof
12/03/2009WO2009103218A8 Ethylidene hydrazine carboxamide derivatives, preparation process and pharmaceutical use thereof
12/03/2009WO2009095503A3 Amino acid derivatives used as pharmaceutical substances
12/03/2009WO2009086426A3 Soluble epoxide hydrolase inhibitors for the treatment of endothelial dysfunction
12/03/2009US20090298830 4-Aryl-2-Amino-Pyrimidnes or 4-Aryl-2-Aminoalkyl-Pyrimidines as Jak-2 Modulators and Methods of Use
12/03/2009US20090298823 Inhibitors of protein kinases
12/03/2009US20090298822 Use of Activators of Soluble Guanylate Cyclase for Treating Reperfusion Damage
12/03/2009US20090297612 Homogeneous, intrinsic radiopaque embolic particles
12/03/2009US20090297598 Therapeutic combination
12/03/2009US20090297503 Blood Coagulation Factor VIII Activation-Enhancing Antibodies
12/03/2009DE202009012159U1 Salbe mit mehreren Schüssler-Salzen Ointment with several Schuessler salts
12/02/2009EP2128265A1 Method for glycosylation of flavonoid
12/02/2009EP2128246A1 Methods and composition for the production of orthoganal tRNA-Aminoacyl-tRNA synthetase pairs
12/02/2009EP2128171A1 Agent for prevention or treatment of iron overload
12/02/2009EP2128163A1 Spiro-ring compound
12/02/2009EP2128158A1 Heterocyclic cyclopropyl-substituted FXR binding compounds
12/02/2009EP2128148A1 Compound, alpha 1 adrenaline receptor antagonist, and composition
12/02/2009EP2127669A1 Use of matrix metalloproteinase-10 (mmp-10) for thrombolytic treatments
12/02/2009EP2125004A1 Synergistic therapeutic use of prothrombin complex concentrates with fviii concentrates
12/02/2009EP2124565A2 N-substituted glycine derivatives: hydroxylase inhibitors
12/02/2009CN101595092A Methods of synthesizing pharmaceutical salts of a factor XA inhibitor
12/02/2009CN101594876A Use of unactivated calcium exchanged zeolites in hemostatic devices and products
12/02/2009CN101594865A Pharmaceutical composition containing low-substituted hydroxypropylcellulose
12/02/2009CN101594864A Method for producing solid preparation
12/02/2009CN101594863A Film-coated preparation having improved stability
12/02/2009CN101591401A Method for preparing low molecular weight heparin with high activity
12/02/2009CN101591376A Oligopeptide with thrombolysis activity, preparation method and application thereof
12/02/2009CN101591346A Novel method for synthesizing related substance B of clopidogrel bisulfate
12/02/2009CN101591344A Antithrombotic compound as well as preparation method and application thereof
12/02/2009CN101591276A Method for preparing bumetanide
12/02/2009CN101590237A Composition containing calcium channel blocker and folic acid as well as application thereof
12/02/2009CN101590235A Composition containing calcium channel blocker and B vitamins as well as application thereof
12/02/2009CN101590234A Composition containing statins and B vitamins as well as application thereof
12/02/2009CN101590233A Composition containing calcium channel blocker, statins and B vitamins as well as application thereof
12/02/2009CN101590219A Refined earthworm protein polypeptide preparation
12/02/2009CN101590210A Chinese medicinal composition for treating cerebraledema and preparation method thereof
12/02/2009CN101590192A Traditional Chinese medicine combination for treating leukemia and preparation method thereof
12/02/2009CN101590188A Chinese medicament for refreshing brain and benefiting intelligence and production technology thereof
12/02/2009CN101590123A Application of traditional Chinese medicine composition in preparing medicament for protecting damaged vascular endothelium
12/02/2009CN101590113A Warming powder of hands and feet
12/02/2009CN101590102A Medicine for treating heart cardiovascular and cerebrovascular diseases and preparation method thereof
12/02/2009CN101590097A Chinese herbal medicine prescription for reducing blood pressure and blood fat and improving sleep
12/02/2009CN101590083A Yinxingdamo oral preparation equivalent to similar intravenous preparation
12/02/2009CN101590049A Composition containing amlodipine, atorvastatin and folic acid as well as new application thereof
12/02/2009CN101590040A Composition containing indapamide and B vitamins as well as application thereof
12/02/2009CN101590039A Composition containing indapamide and statins as well as application thereof
12/02/2009CN101590023A Clopidogrel hydrogen sulfate tablet and preparation method thereof
12/02/2009CN101589803A Chinese angelica and pearl powder product with beauty and health care functions
12/02/2009CN101589801A Process for manufacturing red ginseng honey slice
12/02/2009CN100564397C Low molecular weight heparin triethanolamine salt usable as local delivery antithrombotic treating agent, preparing process and use thereof
12/02/2009CN100564375C (3Z) -3-(2,3-dihydro-1H-ylidene)-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors
12/02/2009CN100563709C Novel targeted tissue factor antibody as anticoagulants
12/02/2009CN100563682C Medicine compound made of haw leaf and rhodiola and its preparation method
12/01/2009US7626074 Method of screening candidate drugs for the treatment of leukemia
12/01/2009US7625937 1H-benzo[F]indazol-5-YL derivatives as selective glucocorticoid receptor modulators
12/01/2009US7625934 Metalloproteinase inhibitors
12/01/2009US7625919 Osteoporosis; oral diseases; bone disorders; atherosclerosis; antiarthritic agents; autoimmune disease; cachexia
12/01/2009US7625883 Choline Salt of L- alpha -glycero-phospho-D-mio-inositol; alpha -glycero-phospho-D-mio-inositol tetrabutylammonium salt; treatment of pathologies mediated by the activation or over stimulation of cytololilc phospholipase-2 (PLA2), particularly, septic shock and viral and bacterial infections
12/01/2009US7625866 Increased content of high molecular weight multimers; hemophilia and blood disorder treatment
12/01/2009US7625752 Enriching stem and progenitor cells by positive or negative selection of hematopoietic cells from umbilical cord blood; culturing under proliferation conditions that increase differentiation potential
12/01/2009CA2444590C Stabilized hemoglobin solutions
12/01/2009CA2401878C Methods and apparatus for stenting comprising enhanced embolic protection, coupled with improved protection against restenosis and thrombus formation
12/01/2009CA2389412C N-guanidinoalkylamides, their preparation, their use, and pharmaceutical preparations comprising them
12/01/2009CA2264556C Substituted n-[(aminoiminomethyl or aminomethyl)phenyl]propyl amides
11/2009
11/26/2009WO2009143039A2 Heterocyclic compounds as factor ixa inhibitors
11/26/2009WO2009142321A1 Novel thiophenediamine derivative having urea structure
11/26/2009WO2009142242A1 Composition for preventing cardiovascular event in high-risk patient
11/26/2009WO2009141418A1 Formulations of peg-functionalised serine proteases with high concentrations of an aromatic preservative
11/26/2009WO2008145281A8 Formulations containing triazinones and iron
11/26/2009US20090292000 Pyrrolidine derivatives as prostaglandin modulators
11/26/2009US20090291995 bis-(monoethanolamine) salt of 3'-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid; enhanced solubility and bioavailability compared with free acid; agonist of TPO receptor, enhances platelet production; thrombocytopenia
11/26/2009US20090291962 2-phenyl-6-aminocarbonyl-pyrimidine derivatives and their use as p2y12 receptor
11/26/2009US20090291952 Modulators of pharmacokinetic properties of therapeutics
11/26/2009US20090291913 FACTOR Xa INHIBITOR FORMULATION AND METHOD
11/26/2009US20090291429 Substances causing differentiation
11/26/2009US20090291086 Compositions and Methods for Treating Cerebral Thrombosis and Global Cerebral Ischemia
11/26/2009CA2724983A1 Composition for preventing cardiovascular event in high-risk patient
11/26/2009CA2724430A1 Heterocyclic compounds as factor ixa inhibitors
11/26/2009CA2724357A1 Novel thiophenediamine derivative having urea structure
11/25/2009EP2123680A1 Recombinant chimeric protein of neutrophil inhibitory factor and hirugen and medicament composition thereof
11/25/2009EP2123675A2 Human EPO mimentic hinge core mimetibodies, compositions, methods and uses
11/25/2009EP2123669A1 Copolymers for suppression of autoimmune diseases, and methods of use
11/25/2009EP2123656A1 Process for production of prasugrel hydrochloride having high purity
11/25/2009EP2123652A1 Heterocyclic compound
11/25/2009EP2123649A1 3-pyrrolo-cyclohexylene-2-dihydro-indolinone derivatives and uses thereof
11/25/2009EP2123287A1 Agent for preventing bleeding from cerebral cortical vein
11/25/2009EP2123270A1 Iron metabolism-improving agent
11/25/2009EP2121704A2 Polymorphic forms of clopidogrel hydrobromide
11/25/2009EP2121017A2 Method for inhibiting the expression of endogenous erythropoietin (epo)
11/25/2009EP2121006A1 Intraperitoneal administration of antithrombin iii, related compositions and methods
11/25/2009EP2120991A1 Treatment of trauma hemorrhage with short oligopeptides
11/25/2009EP1242385B1 Cytokine, especially tnf-alpha, inhibitors
11/25/2009EP1210108B1 Use of leptin together with an inhibitor of vegf and/or an inhibitor of angiogenesis for the inhibition of endothelial cell proliferation
11/25/2009EP0931060B1 Substituted n- (aminoiminomethyl or aminomethyl)phenyl propyl amides
11/25/2009CN101588819A Factor IX moiety-polymer conjugates having a releaseable linkage
11/25/2009CN101585881A An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
11/25/2009CN101585864A Nitrogen-terminal fixed-point coupling method for colony stimulating factor of column chromatography granulocyte and coupled product
11/25/2009CN101585863A Method for preparing yamogenin
11/25/2009CN101585842A Research and control method of impurity B control method in clopidogrel
11/25/2009CN101585770A Caffeic acid diester compounds and prepartion method thereof, and application of preparing medicine for curing thrombus
1 ... 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 ... 671